Iris Pharma and RxGen, Inc. Announce Strategic Alliance
4/19/2012 9:46:28 AM
More...
|
RxGen, Inc. and miRagen Therapeutics Announce Award of National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute SBIR Grant to Fund Advanced Preclinical Studies Evaluating the Role of microRNAs in Cardiac Disease
8/25/2011 10:34:52 AM
More...
|
RxGen, Inc. and Santaris Pharma A/S Use LNA-antimiR Technology to Antagonize the Liver-expressed microRNA-122 in Non-Human Primates and to Safely Lower Serum Cholesterol
3/27/2008 11:09:32 AM
More...
|
RxGen PrimaTox, Inc And BioTrove, Inc. Announce Collaboration
1/30/2006 1:46:17 PM
More...
|
RxGen, Inc. Announces The Formation Of RxGen PrimaTox, Inc., A Subsidiary Focused On Molecular Toxicology In Primates And Humans, Spencer Farr Named CEO
1/26/2006 11:08:44 AM
More...
|
RxGen, Inc. Awarded Phase I Of Fast Track SBIR For Study Of Environmental Causes Of Parkinson's Disease
10/19/2005 5:12:23 PM
More...
|
RxGen, Inc. Provides Preclinical Research Expertise To Support The Development Of Lipid Sciences, Inc.'s (LIPD) Delipidation Technology
10/19/2005 5:11:55 PM
More...
|
RxGen, Inc. Awarded $1.4 Million Fast Track SBIR For Next Generation Predictive Toxicology Program, PrimaTox
10/19/2005 5:11:45 PM
More...
|
RxGen, Inc. Appoints Steven R. Gullans, Former US Genomics CSO, As New Chief Executive Officer
10/19/2005 5:10:08 PM
More...
|
RxGen, Inc. Discovers Genes Associated With Brain Development: Discovery Provides New Insight For Treating Brain Disorders
10/19/2005 5:09:22 PM
More...
|